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SYNOPSIS 
 
Allostery is a commonly used mechanism to regulate the activity of 
proteins, wherein ligand binding to one site of a protein alters the function of 
another site. Thermodynamically, allostery can take place either by a change in the 
mean structure of the protein (enthalpy driven) or by a change in the dynamics of 
the protein (entropy driven) or a combination of both. Structural changes in an 
allosteric protein could be realized by selection of a conformer from a pre-existing 
ensemble of conformers by the allosteric ligand (Monod, Wyman and Changeux 
model), or induction of the structural change on binding of the allosteric ligand 
(Koshland, Nemethy and Filmer model). 
Enzymes are often multidomain proteins, in which a regulatory domain 
modulates the activity of the catalytic domain. The activity of a particular type of 
catalytic domain could be modulated by different types of regulatory domains. 
Such an assembly of protein domains allows for allosteric integration of distinct 
stimuli ‘sensed’ by different regulatory domains into a similar output signal. 
Conversely, a particular type of regulatory domain can modulate the activity of a 
variety of catalytic domains. Such an assembly allows for allosteric dissemination 
of a stimulus into distinct output signals generated by different catalytic domains. 
Cyclic GMP is an important second messenger that has been implicated in 
the regulation of a plethora of physiological and developmental processes, 
including visual signal transduction and smooth muscle contraction. The intricate 
spatial and temporal balance of intracellular cGMP concentration is maintained by 
conversion of GTP to cGMP by guanylyl cyclases (GCs), and hydrolysis of cGMP 
to 5’-GMP by phosphodiesterases (PDEs). Both GCs and PDEs are multidomain 
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proteins, and binding of allosteric modulators such as peptide hormones, nitric 
oxide, ATP, and cGMP to regulatory domains present in these proteins modulates 
the activity of the associated cyclase or phosphodiesterase domains. Therefore, 
understanding mechanisms by which proteins involved in cGMP signaling 
integrate diverse molecular signals, resulting in fine tuning of intracellular cGMP 
levels, is of great interest. The work described in the thesis provides insights into 
the possibility of multiple allosteric mechanisms to regulate the activity of GCs and 
PDEs. 
Previously, an analysis of the sequences of nucleotide cyclase domains 
revealed their convergent evolution, leading to their categorization into different 
classes. GCs belong to class III, or the ‘Universal’ class of nucleotide cyclases. 
Further, based on their localization in the cell, GCs have been divided into two 
groups, namely the membrane bound receptor GCs, and the cytosolic soluble GCs. 
Receptor GCs contain an N-terminal extracellular ligand-binding domain, a 
transmembrane helix, a kinase homology domain, a linker, and a C-terminal 
cyclase domain. Soluble GCs contain an N-terminal HNOB (Heme nitric oxide 
binding) domain followed by the HNOBA (Heme nitric oxide binding associated) 
domain, and a C-terminal cyclase domain. In order to speculate on the allosteric 
regulation of GCs, a large scale bioinformatic analysis of all GC domain-containing 
proteins, present in the non-redundant database (NRDB) of protein sequences, was 
undertaken using various computational tools such as Position Specific Iterated-
Basic Local Alignment Search Tool (PSI-BLAST), hidden Markov Model (HMM)-
based searches, and Molecular Evolutionary Genetics Analysis (MEGA).  
PSI-BLAST searches were performed with 48 seed cyclase domain 
sequences against the NRDB. Stringent search criteria for the presence of essential 
residues that are required for metal ion binding, substrate specificity, and 
transition-state stabilization led to the identification of 199 putative active GCs. 
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Phylogenetic analysis of the cyclase domains of these GCs showed multiple 
lineage-specific expansion of GCs. Detailed sequence analysis revealed the 
conservation of a number of residues in the cyclase domain, including residues 
involved in inter-chain interaction in a dimer of GC domains. Although cGMP is 
commonly thought to be utilized as a second messenger in eukaryotes, the search 
for GCs resulted in the identification of a number of GCs in prokaryotes, thus 
alluding to the possibility of cGMP-mediated signaling in these organisms. 
Further, prokaryotic GC domains were fused to regulatory domains that are not 
commonly found amongst the eukaryotic GCs, suggesting a regulation of these 
GCs by a different set of molecular signals.  
Following the analysis of the cyclase domains, the sequences of the kinase 
homology domains in receptor GCs were analyzed in detail. Results revealed the 
conservation of essential motifs seen in protein kinases, including the VAIK motif 
required for ATP binding. However, all of the kinase homology domains lacked 
the HRD motif, which is required for phosphate group transfer and consequent 
phosphorylation of substrates, suggesting a regulatory, instead of a catalytic, role 
of the kinase homology domain in receptor GCs. Phylogenetic analysis and 
correlation analysis of sequence conservation of the kinase homology domain and 
the cyclase domain sequences revealed coevolution of the two domains, indicating 
a very specific regulation of the cyclase domain by the associated kinase homology 
domain. A similar analysis of the extracellular domain sequences also revealed 
conservation of a number residues and their coevolution with the cyclase domain 
in receptor GCs. 
Observing the coevolution of the kinase homology domain and the cyclase 
domain, efforts were then directed towards analyzing the sequence of residues 
connecting these two domains in receptor GCs. Such an analysis revealed the 
presence of a highly conserved linker region that connects the kinase homology 
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domain and the cyclase domain. Not only the sequence, but also the length of the 
linker region was found to be highly conserved, suggesting a ‘constant’ role of the 
linker region in regulating the activity of the cyclase domain. Thus, the cyclase 
domain in receptor GCs could be allosterically regulated by multiple mechanisms 
via the extracellular domain, the kinase homology domain and the linker region.  
In the course of identifying GCs in the NRDB, three proteins containing 
kinase and cyclase domains were found to be encoded in the mimiviral genome. In 
contrast to the domain architecture of a typical receptor GC, the cyclase domains in 
the mimiviral proteins were flanked by two kinase domains on both sides. 
Sequence analysis of the kinase domains showed the presence of all the critical 
motifs required for kinase activity, while the cyclase domains lacked substrate 
specifying residues. This suggests a regulatory role for the cyclase domain, while 
the kinase domain could act as an active, catalytic domain in these proteins. A 
large scale search for all kinase- and cyclase-domain containing proteins in the 
NRDB was initiated. This search led to the identification of 193 proteins, a majority 
of which were receptor GCs. Interestingly, sequence analysis of these proteins 
revealed that the kinase domain in 18 of the 193 proteins (mostly prokaryotic) 
contained all the critical residues required for phosphorylation. Sequence analysis 
of the cyclase domains in these 18 proteins showed the presence of adenylyl 
cyclase (AC), ambiguous, C1-like or C2-like cyclase domains. However, none of 
them showed the presence of an active GC domain. This suggests that the kinase 
homology domains, lacking critical residues, fused to active GCs play a regulatory 
role as seen in receptor GCs, while the cyclase domains fused to active kinase 
domains, perhaps regulate the activity of the kinase domain in such proteins. 
Following these observations that suggested the possibility of multiple 
mechanisms of allosteric regulation in GCs, studies were initiated to understand 
allosteric regulation in PDEs. The cGMP binding, cGMP specific PDE (PDE5) was 
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chosen as a model protein. PDE5 is a dimeric, multidomain protein, containing two 
regulatory GAF domains (domains present in cGMP phosphodiesterases, Adenylyl 
cyclases, FhlA transcription factor) in tandem at the N-terminus, and a catalytic 
domain at the C-terminus. Cyclic GMP binding to the GAFa domain of PDE5 is 
known to activate the catalytic domain by altering the structure of the protein. 
PDE5 is the target for catalytic domain inhibitors, such as sildenafil and tadalafil, 
that are widely used for the treatment of erectile dysfunction and pulmonary 
hypertension.  
To detect structural changes in the isolated GAFa domain of PDE5 on ligand 
binding, the Bioluminescence Resonance Energy Transfer (BRET) technique was 
employed. For this, a fusion protein containing the isolated GAFa domain 
sandwiched between green fluorescent protein (GFP2) and Renilla luciferase (Rluc) 
at the N- and C-termini, respectively, was generated (GAFa sensor). Since the 
efficiency of resonance energy transfer strongly depends on the distance between 
the GFP2 and the Rluc proteins, a change in the structure of the GAFa domain 
would be detected as an alteration in the energy transfer between Rluc and GFP2. 
Radiolabelled cGMP binding studies with purified GST-GAFa fusion protein 
showed high affinity interaction of cGMP with the GAFa domain. Incubation of 
lysates prepared from cells expressing the GAFa sensor with cGMP resulted in 
increased BRET of the GAFa sensor. Mutation of the F163 residue to Ala severely 
decreased the affinity of the GAFa sensor for cGMP and abolished the change in 
BRET induced by cGMP. Increase in BRET of the GAFa sensor indicated a change 
in the distance or orientation of helices α2 and α5, to which the reporter proteins, 
GFP2 and Rluc, were fused. Analysis of the apo- and the holo-GAF domain 
structures of PDE5 and PDE2 also suggested that ligand binding to the GAF 
domain results in a rotation of helix α5 with respect to helix α2, in addition to the 
closure of the ligand binding pocket. Thus, ligand binding to the GAFa domain 
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may allosterically activate the catalytic domain in PDE5 via a rotation-based 
mechanism. 
To test if ligand binding to the GAFa domain results in a change in the 
structure of the full-length PDE5 as well, BRET experiments were performed with 
a fusion protein containing the full-length PDE5 sandwiched between GFP2 and 
Rluc at the N- and C-termini, respectively (PDE5 sensor). Gel filtration and kinetic 
analysis indicated similar biochemical properties of the PDE5 sensor, as has been 
reported for the native PDE5 protein. Incubation of lysates prepared from cells 
expressing the PDE5 sensor with cGMP resulted in a decrease in BRET, while 
mutation of the F163 residue in the GAFa domain to Ala abrogated the cGMP-
induced reduction in BRET. Further, incubation of lysates with sildenafil also 
resulted in a decrease in BRET that was abrogated by mutation of the F778 residue 
that forms a stacking interaction with sildenafil in the catalytic domain. Therefore, 
cGMP binding to the GAFa domain and sildenafil binding to the catalytic domain 
altered the structure of PDE5 in ways that resulted in a reduction in BRET.  
While it appeared that the structural changes brought about by cGMP and 
sildenafil were similar, mutation of the G617 residue that provides flexibility to the 
mobile H-loop in the catalytic domain abrogated the reduction in BRET seen in the 
presence of sildenafil without affecting the reduction in BRET seen in the presence 
of cGMP. This indicated that the structural changes associated with cGMP binding 
to the GAFa domain and sildenafil binding to the catalytic domain were not 
similar. Moreover, sequential incubation of the PDE5 sensor with cGMP and 
sildenafil showed that while sildenafil binding to the catalytic domain allosterically 
increased cGMP affinity to the GAFa domain, cGMP failed to alter sildenafil 
affinity to the catalytic domain. 
Attempts were then made to study cGMP-induced activation of PDE5 in 
intact cells. Elevation of intracellular cGMP levels did not result in a significant 
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change in BRET, while incubation with sildenafil resulted in a low, but significant, 
reduction in BRET. Therefore, it appeared that components in the buffer used for in 
vitro experiments promoted the reduction in BRET of the PDE5 sensor seen in the 
presence of cGMP. Thorough analysis of the buffer components revealed that 
EDTA was required for the cGMP-induced conformational change, while presence 
of divalent metals such as Mg2+, Mn2+, or Ca2+, abolished the cGMP-induced 
conformational change in PDE5.  Determination of cGMP hydrolysis in the 
presence of the Mg2+, Mn2+, and Ca2+ showed that the abrogation of cGMP-induced 
conformational in PDE5 by these metal ions was due to allosteric regulation of the 
PDE5 structure, and not because of cGMP hydrolysis by the catalytic domain. 
Indeed, experimentally reducing intracellular levels of divalent metal ions resulted 
in a reduction in BRET of the PDE5 sensor on elevation of cGMP levels in intact 
cells. Incubation of the PDE5 sensor with metal ions allosterically decreased the 
EC50 of sildenafil-induced conformational change. These effects of metal ions were 
lost when the metal ion-anchoring D612 residue, present in the catalytic domain, 
was mutated to Ala, indicating that the binding of catalytic metal ions modulated 
the structure of PDE5.  
A number of observations indicated that binding of cGMP, sildenafil, and 
metal ions resulted in distinct changes in the structure of PDE5. To conclusively 
determine if binding of these ligands indeed resulted in distinct structural effects, 
the thermodynamic bases for the conformational transition associated with binding 
of the ligands were determined. The extent of alteration in BRET of the PDE5 
sensor in the presence of different ligands was monitored under a range of 
temperatures. While the cGMP-induced conformational change was temperature-
independent, sildenafil and metal ion-induced effects were found to be 
temperature-dependent. Estimation of thermodynamic parameters based on 
Arrhenius plots and the Eyring equation revealed that the cGMP-induced 
conformational transition largely involved changes in entropy, while sildenafil- 
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and metal ion-induced effects largely involved changes in enthalpy. Thus, binding 
of cGMP, sildenafil, and metal ions not only resulted in distinct changes in the 
structure of PDE5, but in addition, the thermodynamic bases underlying the 
observed structural effects were distinct. 
Results presented in the thesis provide insights into various mechanisms of 
allosteric regulation of proteins involved in cGMP signal transduction. 
Bioinformatic analysis indicated the regulation of GC cyclase domain by the kinase 
homology domain and linker region joining the kinase homology domain and the 
cyclase domain, in addition to the regulation seen following ligand binding to the 
extracellular domain of these receptors. Binding of cGMP, sildenafil, and metal 
ions to PDE5 resulted in distinct conformational changes with distinct 
thermodynamic bases. Therefore, the activity of the proteins involved in cGMP 
signal transduction and multi-domain proteins in general, could be regulated by 
different molecular signals in many distinct ways. 
 
  
